Equine Encephalitis Virus Vaccine: Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial

The trial will evaluate the safety, tolerability, and immunogenicity of MVA-BN WEV in 45 healthy adults in three treatment groups receiving different doses of the vaccine.

Content Information

Content Author: 
Content Source: 
Outbreak News Today
Content Type: